Essential Testing Following a DLBCL Diagnosis

preview_player
Показать описание
Following a diffuse large B-cell lymphoma (DLBCL) diagnosis, essential testing should follow. Expert Dr. Loretta Nastoupil explains DLBCL tests that help determine prognosis and guide treatment options for each patient.

  1. Patient Empowerment Network
  2. Dr. Loretta Nastoupil
  3. MD Anderson Cancer Center
  4. University of Texas MD Anderson Cancer Center
  5. DLBCL
  6. diffuse large B-cell lymphoma
Рекомендации по теме
Essential Testing Following 0:03:49

Essential Testing Following a DLBCL Diagnosis

Key Steps Following 0:02:17

Key Steps Following a DLBCL Diagnosis

Debate: How should 0:15:16

Debate: How should patients with ABC type DLBCL be treated today? - R-CHOP

Rationale for Genetic 0:00:34

Rationale for Genetic Testing in Patients With DLBCL

How Does Biomarker 0:02:14

How Does Biomarker Testing Impact DLBCL Treatment Options?

DLBCL Treatment Decisions: 0:34:07

DLBCL Treatment Decisions: What’s Right for You?

Relapsed and Refractory 0:46:48

Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Prognostic Factors in 0:06:44

Prognostic Factors in DLBCL

Understanding High-Risk DLBCL 0:09:27

Understanding High-Risk DLBCL

Perspectives on Novel 1:24:16

Perspectives on Novel Antibody Platforms in DLBCL

REDLAMP 14: Does 0:07:14

REDLAMP 14: Does Routine Imaging After DLBCL Remission Improve Post-Treatment Survival?

Highlights from the 0:21:40

Highlights from the International Conference on Malignant Lymphoma in Lugano

What Are the 0:05:40

What Are the Goals of DLBCL Treatment?

Can we use 0:20:16

Can we use Patient-derived Xenografts to Assess New Lymphoma Therapies?

What to Do 1:10:44

What to Do After a Cancer Diagnosis | For Non-Hodgkin Lymphoma Patients and Caregivers

Dr. Dogan on 0:01:35

Dr. Dogan on Updated WHO Classifications in DLBCL

How Is DLBCL 0:02:45

How Is DLBCL Treatment Effectiveness Monitored?

Elucidating the genetic 0:02:27

Elucidating the genetic and molecular basis of DLBCL

Peripheral T-Cell Lymphoma: 0:27:06

Peripheral T-Cell Lymphoma: What is New on the Horizon?

Lymphoma 101: The 2:09:37

Lymphoma 101: The best new treatments for Lymphoma and how to get them.

Circulating Tumor DNA 0:02:31

Circulating Tumor DNA as a Detection Tool Following #DLBCL Therapy | Mark Roschewski, MD | ASH 2023

DLBCL and other 0:49:42

DLBCL and other Aggressive Non Hodgkin Lymphomas

DLBCL Risk Assessment 0:07:40

DLBCL Risk Assessment and Genetic Signatures

The evolving role 0:02:30

The evolving role of MRD in DLBCL